Medicine
Latisse 0.3 mg/mL eye drops
Latisse 0.3 mg/mL eye drops is a prescription medicine containing Bimatoprost for ophthalmic use, marketed by Allergan, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 2º to 25ºC (36º to 77ºF).
Key facts
- Active ingredient (INN)
- Bimatoprost
- Brand
- Latisse
- Strength
- 0.3 mg/mL
- Dosage form
- Eye drops
- Route
- Ophthalmic
- Packs
- 1 bottle
- Marketing authorisation holder
- Allergan
- Manufacturer
- Allergan
- Origin register
- US FDA, United States
- Storage
- Store at 2º to 25ºC (36º to 77ºF).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01EE03 Bimatoprost
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 January 2009
- Identifiers
- RxCUI 1041495, 1041497DailyMed set ID 34f83d9d-2c64-463e-8a90-9a460fedfeadNDC 0023-3616Application NDA022369
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Bimatoprost 0.3 mg/mL eye drops.
Other strengths and forms of Bimatoprost
Clinical summary
Bimatoprost is a prostaglandin analog indicated to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness. It is available as eye drops, implants and ophthalmic gel for intracameral use. MedsAcross supplies Bimatoprost for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BimatoprostFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- LATISSE prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
- Lumigan: European public assessment report (EPAR) · European Medicines Agency
Need Latisse 0.3 mg/mL eye drops for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.